The identification of BRP, an anti-obesity peptide, showcases the transformative role of AI in drug discovery and its ...

The lab of Dan Xu, PhD, assistant professor at The Hormel Institute, has published a groundbreaking study in Cell Metabolism, a highly prestigious scientific journal. The paper, entitled "Isoform ...

ZyVersa Therapeutics (ZVSA) highlights newly published animal model data demonstrating that inflammasome inhibition attenuates ...

Updated results from BP1001-A obesity and Type 2 diabetes testing from the second stage of pre-clinical testing are as follows: Previously, Bio-Path reported BP1001-A increased insulin sensitivity in ...

BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...

Obesity is a global health concern closely linked to a range of metabolic diseases, such as type 2 diabetes and ...

UD researchers discover that differences in gene expression in fat could be the key to targeted obesity treatment. According ...

With health care costs rising and obesity-related conditions impacting workplace productivity, employers are increasingly ...

Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to treating cardiometabolic diseases driven ...

Food labeled and prepared for college student and research subject Sam Srisatta sits on a tray in a kitchen during a study on ...

Roche has entered an exclusive collaboration and licensing agreement with Danish obesity drug maker Zealand Pharma to ...